Targeting positive regulatory domain I-binding factor 1 and X box-binding protein 1 transcription factors by multiple myeloma-reactive CTL
Growing evidence indicates that multiple myeloma (MM) and other malignancies are susceptible to CTL-based immune interventions. We studied whether transcription factors inherently involved in the terminal differentiation of mature B lymphocytes into malignant and nonmalignant plasma cells provide MM...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
[July 15, 2005]
|
| In: |
The journal of immunology
Year: 2005, Jahrgang: 175, Heft: 2, Pages: 1301-1309 |
| ISSN: | 1550-6606 |
| DOI: | 10.4049/jimmunol.175.2.1301 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.4049/jimmunol.175.2.1301 Verlag, lizenzpflichtig, Volltext: https://www.jimmunol.org/content/175/2/1301 
|
| Verfasserangaben: | Carina Lotz, Sarah Abdel Mutallib, Nicole Oehlrich, Ulrike Liewer, Edite Antunes Ferreira, Marion Moos, Michael Hundemer, Sandra Schneider, Susanne Strand, Christoph Huber, Hartmut Goldschmidt, and Matthias Theobald |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 179388871X | ||
| 003 | DE-627 | ||
| 005 | 20220820134846.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220225s2005 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.4049/jimmunol.175.2.1301 |2 doi | |
| 035 | |a (DE-627)179388871X | ||
| 035 | |a (DE-599)KXP179388871X | ||
| 035 | |a (OCoLC)1341445322 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Lotz, Carina |d 1972- |e VerfasserIn |0 (DE-588)128692944 |0 (DE-627)377825816 |0 (DE-576)29728245X |4 aut | |
| 245 | 1 | 0 | |a Targeting positive regulatory domain I-binding factor 1 and X box-binding protein 1 transcription factors by multiple myeloma-reactive CTL |c Carina Lotz, Sarah Abdel Mutallib, Nicole Oehlrich, Ulrike Liewer, Edite Antunes Ferreira, Marion Moos, Michael Hundemer, Sandra Schneider, Susanne Strand, Christoph Huber, Hartmut Goldschmidt, and Matthias Theobald |
| 264 | 1 | |c [July 15, 2005] | |
| 300 | |b Diagramme | ||
| 300 | |a 9 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 25.02.2022 | ||
| 520 | |a Growing evidence indicates that multiple myeloma (MM) and other malignancies are susceptible to CTL-based immune interventions. We studied whether transcription factors inherently involved in the terminal differentiation of mature B lymphocytes into malignant and nonmalignant plasma cells provide MM-associated CTL epitopes. HLA-A*0201 (A2.1) transgenic mice were used to identify A2.1-presented peptide Ag derived from the plasma cell-associated transcriptional regulators, positive regulatory domain I-binding factor 1 (PRDI-BF1) and X box-binding protein 1 (XBP-1). A2.1-restricted CTL specific for PRDI-BF1 and XBP-1 epitopes efficiently killed a variety of MM targets. PRDI-BF1- and XBP-1-reactive CTL were able to recognize primary MM cells from A2.1+ patients. Consistent with the expression pattern of both transcription factors beyond malignant and nonmalignant plasma cells, PRDI-BF1- and XBP-1-specific CTL activity was not entirely limited to MM targets, but was also associated with lysis of certain other malignancies and, in defined instances, with low-to-intermediate level recognition of a few types of normal cells. Our results also indicate that the A2.1-restricted, PRDI-BF1- and XBP-1-specific human CD8+ T cell repertoire is affected by partial self tolerance and may thus require the transfer of high-affinity TCR to break tolerance. We conclude that transcription factors governing terminal cellular differentiation may provide MM- and tumor-associated CTL epitopes. | ||
| 700 | 1 | |a Mutallib, Sarah Abdel |e VerfasserIn |4 aut | |
| 700 | 1 | |a Oehlrich, Nicole |e VerfasserIn |4 aut | |
| 700 | 1 | |a Liewer, Ulrike |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ferreira, Edite Antunes |e VerfasserIn |4 aut | |
| 700 | 1 | |a Moos, Marion |e VerfasserIn |0 (DE-588)1243124318 |0 (DE-627)1773573187 |4 aut | |
| 700 | 1 | |a Hundemer, Michael |d 1972- |e VerfasserIn |0 (DE-588)128390549 |0 (DE-627)372634001 |0 (DE-576)297117998 |4 aut | |
| 700 | 1 | |a Schneider, Sandra |e VerfasserIn |4 aut | |
| 700 | 1 | |a Strand, Susanne |e VerfasserIn |4 aut | |
| 700 | 1 | |a Huber, Christoph |e VerfasserIn |4 aut | |
| 700 | 1 | |a Goldschmidt, Hartmut |d 1956- |e VerfasserIn |0 (DE-588)102258023X |0 (DE-627)717003809 |0 (DE-576)365637386 |4 aut | |
| 700 | 1 | |a Theobald, Matthias |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The journal of immunology |d Rockville, Md. : American Association of Immunologists, 1916 |g 175(2005), 2 vom: Juli, Seite 1301-1309 |h Online-Ressource |w (DE-627)269535217 |w (DE-600)1475085-5 |w (DE-576)079963838 |x 1550-6606 |7 nnas |a Targeting positive regulatory domain I-binding factor 1 and X box-binding protein 1 transcription factors by multiple myeloma-reactive CTL |
| 773 | 1 | 8 | |g volume:175 |g year:2005 |g number:2 |g month:07 |g pages:1301-1309 |g extent:9 |a Targeting positive regulatory domain I-binding factor 1 and X box-binding protein 1 transcription factors by multiple myeloma-reactive CTL |
| 856 | 4 | 0 | |u https://doi.org/10.4049/jimmunol.175.2.1301 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.jimmunol.org/content/175/2/1301 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20220225 | ||
| 993 | |a Article | ||
| 994 | |a 2005 | ||
| 998 | |g 102258023X |a Goldschmidt, Hartmut |m 102258023X:Goldschmidt, Hartmut |d 910000 |d 910100 |d 50000 |e 910000PG102258023X |e 910100PG102258023X |e 50000PG102258023X |k 0/910000/ |k 1/910000/910100/ |k 0/50000/ |p 11 | ||
| 998 | |g 128390549 |a Hundemer, Michael |m 128390549:Hundemer, Michael |d 910000 |d 910100 |e 910000PH128390549 |e 910100PH128390549 |k 0/910000/ |k 1/910000/910100/ |p 7 | ||
| 998 | |g 1243124318 |a Moos, Marion |m 1243124318:Moos, Marion |d 910000 |d 910100 |e 910000PM1243124318 |e 910100PM1243124318 |k 0/910000/ |k 1/910000/910100/ |p 6 | ||
| 999 | |a KXP-PPN179388871X |e 4073162497 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"id":{"eki":["179388871X"],"doi":["10.4049/jimmunol.175.2.1301"]},"note":["Gesehen am 25.02.2022"],"language":["eng"],"person":[{"given":"Carina","family":"Lotz","role":"aut","display":"Lotz, Carina"},{"family":"Mutallib","given":"Sarah Abdel","role":"aut","display":"Mutallib, Sarah Abdel"},{"role":"aut","display":"Oehlrich, Nicole","given":"Nicole","family":"Oehlrich"},{"display":"Liewer, Ulrike","role":"aut","given":"Ulrike","family":"Liewer"},{"given":"Edite Antunes","family":"Ferreira","display":"Ferreira, Edite Antunes","role":"aut"},{"family":"Moos","given":"Marion","role":"aut","display":"Moos, Marion"},{"role":"aut","display":"Hundemer, Michael","given":"Michael","family":"Hundemer"},{"given":"Sandra","family":"Schneider","display":"Schneider, Sandra","role":"aut"},{"role":"aut","display":"Strand, Susanne","given":"Susanne","family":"Strand"},{"family":"Huber","given":"Christoph","role":"aut","display":"Huber, Christoph"},{"given":"Hartmut","family":"Goldschmidt","display":"Goldschmidt, Hartmut","role":"aut"},{"display":"Theobald, Matthias","role":"aut","family":"Theobald","given":"Matthias"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"title":[{"title":"Targeting positive regulatory domain I-binding factor 1 and X box-binding protein 1 transcription factors by multiple myeloma-reactive CTL","title_sort":"Targeting positive regulatory domain I-binding factor 1 and X box-binding protein 1 transcription factors by multiple myeloma-reactive CTL"}],"recId":"179388871X","physDesc":[{"extent":"9 S.","noteIll":"Diagramme"}],"relHost":[{"name":{"displayForm":["American Association of Immunologists"]},"origin":[{"dateIssuedKey":"2025","dateIssuedDisp":"2025-","publisher":"Oxford University Press ; Soc. ; American Association of Immunologists","publisherPlace":"Oxford ; Bethesda, Md. ; Rockville, Md."}],"recId":"269535217","corporate":[{"display":"American Association of Immunologists","role":"isb"}],"note":["Gesehen am 18.08.2025"],"part":{"issue":"2","text":"175(2005), 2 vom: Juli, Seite 1301-1309","year":"2005","pages":"1301-1309","volume":"175","extent":"9"},"pubHistory":["1.1916 -"],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"journal of immunology","title":"The journal of immunology"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng"],"disp":"Targeting positive regulatory domain I-binding factor 1 and X box-binding protein 1 transcription factors by multiple myeloma-reactive CTLThe journal of immunology","id":{"issn":["1550-6606"],"zdb":["1475085-5"],"eki":["269535217"]}}],"origin":[{"dateIssuedDisp":"[July 15, 2005]","dateIssuedKey":"2005"}],"name":{"displayForm":["Carina Lotz, Sarah Abdel Mutallib, Nicole Oehlrich, Ulrike Liewer, Edite Antunes Ferreira, Marion Moos, Michael Hundemer, Sandra Schneider, Susanne Strand, Christoph Huber, Hartmut Goldschmidt, and Matthias Theobald"]}} | ||
| SRT | |a LOTZCARINATARGETINGP1520 | ||